Christine Mather

Title: Christine Mather: Innovator in Avian Stem Cell Research

Introduction

Christine Mather is a prominent inventor based in Millbrae, CA (US). She has made significant contributions to the field of biotechnology, particularly in the area of avian embryonic stem cell research. Her innovative work has the potential to advance genetic studies and transgenic applications in birds.

Latest Patents

Christine Mather holds a patent for her invention titled "Chimeric bird from embryonic stem cells." This patent describes a method for sustaining cultures of avian embryonic stem cells. The injection of these cells into recipient embryos results in chimeras that exhibit a significant contribution from the embryonic stem cell phenotype. The transgenes encoding exogenous proteins are stably integrated into the embryonic stem cells and are present in the somatic tissue of the resulting chimeras. These transgenes can encode proteins expressed in various tissue types, including endodermal, ectodermal, mesodermal, or extra embryonic tissue. Breeding the resulting chimera produces transgenic birds with genomes that include exogenous DNA.

Career Highlights

Christine Mather is currently associated with Origen Therapeutics, Inc., where she continues her research and development in the field of biotechnology. Her work is pivotal in exploring the applications of stem cell technology in avian species.

Collaborations

Christine collaborates with notable colleagues, including Marie-Cecile Van De Lavoir and Robert Etches. Their combined expertise enhances the research efforts at Origen Therapeutics, Inc.

Conclusion

Christine Mather's innovative contributions to avian embryonic stem cell research exemplify the potential of biotechnology in advancing genetic studies. Her patent and ongoing work at Origen Therapeutics, Inc. highlight her role as a leading inventor in this specialized field.